dr deagle's h1n1 report

7/31/2019 Dr Deagle's H1N1 Report

1/61

LAB ORIGINS OFA H1N1 MEXICAN

FRANKENFLU &TOXIC EUGENIC

MANDATORY

VACCINESDR BILL DEAGLE MD

DABFP AAEM A4M

NUTRIMEDICAL.COMLABVIRUS.COM BLOG


2/61

RESCUE FROM PANDEMIC FLU& TOXIC VACCINES

WHO UN EUGENICSPOPULATION CONTROL

TIMETHEHIntroduction

Strategy

Challenges Forward3

2

1 ORIGINS OF PANDEMIC FLU


3/61

A H1N1

LABFLU2009

H5N1

AVIANFLU1997

1918

H1N1SWINE

FLU

VACCINE

MISHAP

&

EUGENIC

BIOWEAPONS


4/61

LAB ORIGINS OF A H1N1SWINE FLU


5/61

1917 TYPHUS VACCINE SWINE FLU ORIGINS AS

RECOMBINANT SWINE AND HUMAN FLU DR HENRY L. NIMAN DR BILL DEAGLE

MD AUGUST 2006 REVIEW OF PROOFOF WSN33 OLDEST HUMAN AND IOWA

PIG FLU RECOMBINANT ORIGINS OF1918 FLU

TYPHUS VACCINE PASSED THROUGH

PIGS ON VACCINE FACILITY FT.LUPTON, KANSAS, USA

SPONTANEOUS RECOMBINANTINFECTED TROOPS HEADED ON AIR

TROOP TRANSPORTS TO SPAIN, WWI


6/61

RESURRECTION OF THE 1918PANDEMIC SWINE FLU

1951 US TEAM FAIL TO GROW VIRUS IN LABCULTURE FROM ALASKA EXUMED VICTUMS OF

1918 SWINE FLU 1997 MARCH 16TH BASEL, SWITZERLAND -

HUMAN LIFE INTERNATIONAL PRIVATE BOARDMEETING 3 PROJECTS

LATE 90s - DR TAUBENBERG PhD CDC HEADSTEAM TO USE PROMIS ORACLE 8iSUPERCOMPUTER SOFTWARE TO RESURRECTGENE FRAGMENTS 1918 FLU Ref: Dr True OttPhD ND


7/61

WHO UN GLOBAL EUGENICS

POPULATION PROJECTS:

1- PLAMID ANTI-HCG PLACENTALABORTION VACCINATIONAFRICA,

PHILLIPINES AND SOUTH AMERICA

2 SPECIAL VIRUS PROJECTMYCOPLASMA HOSTED RNA

RETROVIRUS IMMUNE FAILURE ANDCANCERAIDS VIRUS

3 RESURRECTED PANDEMIC FLU1918AVIAN SWINE BINARY

WEAPON


8/61

NOVARTIS PHARMA ORACLE 8i

VIRAL RESURRECTION FOUR NATIONS USA CDC, NIAID, USAMRID

CANADA NATL MICROBIOLOGY, WINNIPEG, BRITAIN,ISRAEL BIOWEAPONS NEGEV

SUCCESSFUL RESURRECTION OF H1N1 NOVEL VIRUSWSN33 HUMAN AND

IOWA PIG FLU RECOMBINANT WITH NOVARTISORACLE 8i SUPERCOMPUTER AND BIOENGINE GENESEQUENCER

2007 PATENT FOR NOVEL H1N1 VIRUS APPLICATION

SOURCEs: 1997 HLI Zurich, Switzerland WHOUN, and 2009 ResearchDr True Ott PhD ND &Don Nicoloff Novartis DayCart Daylight Oracle 8i

Supercomputer Predictive Software


9/61

BIOENGINEERED SUPERCOMPUTER

ORACLE 8i LABVIRUS PLAQUE FLU Novartis patent specifically details that the viral

pathogen which the patented vaccine is designedto protect against is a

Reverse Engineered Designer Virus that couldonly have been created in the labs of

Ft. Detrick utilizing ORACLE 8i equippedcomputers.

EXACTLY what Michael Riconosciuto testifiedabout years earlier concerning the BiologicalWarfare capabilities of ORACLE 8i software.

Source: Dr True Ott PhD ND


10/61

VACCINE-INDUCED DISEASE

EPIDEMIC OUTBREAKS (V.I.D.E.O.s)

The Engineering of Pandemics

By A. True Ott, PhD, ND

AMA, JOHN D ROCKEFELLER 1921

PROOF ADVERTISERS PROTECTIVE BUREAUKANSAS SMALLPOX VACCINE DISEASE EPIDEMIC

VACCINES CONTAIN LIVE VIRUSES, ONLY WEAKENEDOR ATTENUATED THAT CAN CAUSE DISEASE

V.I.D.E.O.s IS AN EFFICIENT TOOL OF SOCIALMANIPULATION OF LARGE GROUPS OF POPULATION

AND GENERATING BILLIONS IN PROFIT

ALL THE PANDEMICS OF THE 20THAND EARLY 21ST

CENTURY INCLUDING AIDS, LYME, AND SWINE FLU


11/61

RESURRECTING PANDEMIC FLU OF 1918

1997 RELEASE OF UPGRADED AVIAN H5N1 FLU :

NEW NS1 FOUR AMINO ACID DELETION BYPASSINGIL4 IMMUNE ALARM,

OLD 1918 PB2 AND OTHER LETHAL GENETIC SNPs

FROM 1918 WNS33 HUMAN / IOWA 1930 PIG FLURECOMBINANT VIA TYPHUS PASS-THROUGHCOMINGLING OF VIRUSES IN PIGS

H GENE 6 BASIC AMINO ACIDS CHANGE FROM 1971U OF EDIBURGH, SCOTLAND H5N1 FLU WHO

REFERENCE LAB SEQUENCES ONLY 3 OF 5 AMINO ACIDS IN RECEPTOR BINDING

DOMAIN TO ATTACH TO HUMAN CELLS ON H GENE

A H1N1 MEXICAN LABVIRUS HAS ALL FIVERECEPTOR BINDING H GENES, 2.3 TIMES FASTER

TRIMER OF PB1, PB2 AND PA GENETIC REPLICATION


12/61

CDC A H1N1 MEXICAL FLU

ELECTRON MICROSCOPY


13/61

A H1N1 TRIPLE TRIPLE

LABVIRUS RECOMBINANT


14/61

A H1N1 SWINE MEDICANN FRANKENVIRUS

FOUR SOURCES & THREE CONTINENTS 6 TO 8 % NO DATABASE GENE MATCHES


15/61

DR ADRIAN GIBBS PhD VIRAL GENETICS

LAB RECOMBINANT ORIGINS


16/61

LAB ORIGINS OF A H1N1

PANDEMIC SWINE FLU


17/61

Resurrected Pandemic Influenza Viruses

Terrence M. Tumpey and Jessica A.Belser

Influenza Division, National Center forImmunization and Respiratory Diseases,Centers

for Disease Control and Prevention,

Atlanta, Georgia 30333; email:[email protected]


18/61

PLASMID ENGINEERED FLU VIRUSES


19/61


Abstract Influenza viruses continue to pose a major global public health problem.

There is a need to better understand the pathogenicity and transmission

of pandemic influenza viruses so that we may develop improved methods

for their prevention and control. Reconstruction of the 1918 virus

and studies elucidating the exceptional virulence and transmissibility of

the virus are providing exciting new insights into this devastating pandemic

strain. The primary approach has been to reconstruct and analyze

recombinant viruses, in which genes of the 1918 virus are replaced with

genes of contemporary influenza viruses of lesser virulence. This review

highlights the current status of the field and discusses the molecular determinants of the 1918 pandemic virus that may have contributed to

its virulence and spread. Identifying the exact genes responsible for the

high virulence of the 1918 virus will be an important step toward understanding

virulent influenza strains and will allow the world to better

prepare for and respond to future influenza pandemics.


20/61


The high replication efficiency of the reconstructed

1918 virus observed in mouse and human airway cells appears tobe the result of molecular determinants in the HA, NA, and PB1

virus genes. The role of PB1 may reflect the polymerase activity of the PB1

protein itself or the proapoptotic viral protein, PB1-F2, generatedby an alternative reading frame in the PB1 gene segment.

While the role of the PB1 gene is likely to be crucial component of1918 virus virulence, PB2 appears to contribute to the

transmissibility of this virus by allowing increased replication atlower temperatures in the airways of mammals.

Although a number of selected 1918 virus genes were critical, it ismost certainly the coordinated expression ofall 1918 virus genesthat confers the unique highly virulent, transmissible phenotypeobserved with this pandemic virus.


21/61

Resurrected Pandemic Influenza Viruses 1. Sequence analysis of the 1918H1N1viral

genome and the plasmid-based reverse geneticssystem has allowed researchers an

unprecedented opportunity to study thecomposition of the virus responsible for theinfluenza pandemic of 1918.

2. Among the eight 1918 gene segments studied,the HA, NA, and PB1 genes contributedsignificantly to the efficient replication andenhanced virulence of the pandemic strain.

3. The surface glycoproteins and PB2 segmentsof the 1918 virus are sufficient to confer virus

transmissibility of an avian H1N1 virus.


22/61

Top Cited Literature by Dr Tumpey & Belser

Demonstrated that viruses possessing the1918 NS gene segment were attenuated in mice.

7. Basler CF, Reid AH, Dybing JK, Janczewski TA,Fanning TG, et al. 2001. Sequence of the 1918 pandemic

influenza virus nonstructural gene (NS) segment andcharacterization of recombinant viruses bearing the1918 NS genes. Proc. Natl. Acad. Sci. USA 98:274651

Identified that glycan topology, as well as glycancomposition, affects receptor binding of influenza

viruses. 11. Chandrasekaran A, Srinivasan A, Raman R,

Viswanathan K, Raguram S, et al. 2008. Glycan topologydetermines human adaptation of avian H5N1 virushemagglutinin. Nat. Biotechnol. 26:10713


23/61


Documents the discovery of PB1-F2 protein, generatedby an alternative reading frame of the influenza PB1gene.

13. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, et

al. 2001. A novel influenza A virus mitochondrial proteinthat induces cell death. Nat. Med. 7:130612

Describes the plasmid-based reverse genetics system

used to rescue influenza A viruses in cell culture.

21. Fodor E, Devenish L, Engelhardt OG, Palese P,

Brownlee GG, Garcia-Sastre A. 1999. Rescue ofinfluenza A virus from recombinant DNA. J. Virol.73:967982


24/61


Testing of singlegene H1N1 reassortant 1918 virusesidentified crucial role of HA, NA, and PB1 segments invirus replication and virulence.

74. Pappas C, Aguilar PV, Basler CF, Solorzano A, Zeng

H, et al. 2008. Single gene reassortants identify a criticalrole for PB1, HA, and NA in the high virulence of the1918 pandemic influenza virus. Proc. Natl. Acad. Sci.USA 105:306469

Reported the first documented influenza outbreak caused by a

wholly avian virus directly transmitting to humans frominfected poultry and causing death.

94. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, et al.1998. Characterization of an avian Influenza A (H5N1) virusisolated from a child with a fatal respiratory illness. Science279:39396


25/61


Describes the initial isolation and phylogenetic analysisof multiple genes of 1918 virus sequences, which areconsistent with an H1N1 influenza A virus belonging tothe subgroup of strains that infects humans.

98. Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE,Fanning TG. 1997. Initial genetic characterization of the1918 Spanish influenza virus. Science275:179396

First report characterizing the fully reconstructed 1918virus, including mammalian challenge data.

103. Tumpey TM, Basler CF, Aguilar PV, Zeng H,Solorzano A, et al. 2005. Characterization of thereconstructed 1918 Spanish influenza pandemic virus.

Science310:7780


26/61

REVERSE ENGINEERED FLU

PLAGUES & THERAPEUTICS


27/61

WORLD DEPOPULATION IS TOP

NSA AGENDA - CLUB OF ROME National Security Council's Ad Hoc Group onPopulation Policy.

Policy-planning group is in the U.S.State

Department's Office of Population Affairs,established in 1975 by Henry Kissinger, StateDepartment's Office of Population Affairs(OPA).

This group drafted the Carter administration'sGlobal 2000 document

National Security Study Memorandum 200"(NSSM 200)... "food as a weapon Kissinger


28/61


NSA AGENDA - CLUB OF ROME The sphere of Kissinger In 1975, OPAwas brought under a reorganized StateDepartment Bureau of Oceans,

International Environmental, and ScientificAffairs-- a body created byHenry Kissinger.

The agency was assigned to carry out thedirectives of the NSC Ad Hoc Group.


29/61

WORLD DEPOPULATION IS TOPNSA AGENDA - CLUB OF ROME

Kissinger initiated both groups after discussionwith leaders of the Club of Rome during the 1974population conferences in Bucharest and Rome.

The Club of Rome, controlled by Europe's blacknobility, is the primary promotion agency for thegenocidal reduction of world population levels.

The Ad Hoc Group was given "high priority" by

the Carter administration, through the interventionof National Security Adviser Zbigniew Brzezinskiand Secretaries of State Cyrus Vance andEdmund Muskie.


30/61


NSA AGENDA - CLUB OF ROME Bureau of Oceans, InternationalEnvironmental, and Scientific Affairs hasconsistently blocked industrialization

policies in the Third World, Denying developing nations access to

nuclear energy technology--the policies

that would enable countries to sustain agrowing population.


31/61

NEW LAWS AND PLANS FOR THEPERFECT PANDEMIC FLU STORM

Public Readiness and Emergency PreparednessAct 0f 2006.

US government is using laws designed for dealingwith a very deadly pandemic, or bioterrorism, tobring about a mass vaccination program for swineflu

This law removes liability from the manufacturer,medical practitioners who use the product, andfrom "government program planners" who decidedon using the law


32/61

NATIONAL GOVT TO WHO UN

PANDEMIC FLU CONTROL MODEL STATE EMERGENCY HEALTH POWERS ACTS NATIONAL SECURITY PRESIDENTIAL DIRECTIVE/NSPD 51

and

HOMELAND SECURITY PRESIDENTIAL DIRECTIVE/HSPD-20

National Emergency Act SEIZURE OF TRANSPORT,PROPERTY, FOOD, ETC.

PANDEMIC LEVEL 6 TRANSFER ALL CONTROL TO WHO UNCONTROL 2005 S.P.P. SECURITY AND SECURITY &PROSPERITY PARTNERSHIP AND

2006 SIGNED194 NATIONS NEW UN WHO TREATY OFPANDEMIC CONTROL BY WHO AND UN AUTHORITIES

HHS HEALTH AND HUMAN SERVICES OBAMA ADMIN HHSSEC. SEBELIUS MANDATORY VOLUNTARY WITHCONSEQUEN CES NATIONAL VACCINE FALL 2009 WINTER

2010


33/61

NEW LAWS AND PLANS FOR THE

PERFECT PANDEMIC FLU STORM

Tamiflu and Relenza protection fromliability Tamiflu Hallucinogenic Angel

Dust

Novel Vaccine Adjuvants MF 59 Novartis,and AS03 Glaxo Smith Kline Squalene

oil based super adjuvants and Tween +gp120 glycoprotein amplifier ( adjuvantswill be used in vaccines to stretch thesupply)


34/61

NEW LAWS AND PLANS FOR THE

PERFECT PANDEMIC FLU STORM

Novartis began testing in humans in July, 2009

Sanofi-Aventis and Glaxo Smith Kline in August

,2009 Attenuated viruses WITHOUT adjuvant toxoins

HHS is lobbying FDA to approve dangerousprotein antigen sparing adjuvants and vaccine

grown on non-egg cell lines from aborted baby celllines with various viral oncogenic , mycoplasma,and bacterial contaminants


35/61


Congressional Research Service, on April 27, 2009, theFood and Drug Administration issued fourEmergency Use

Authorizations (enacted in Section 564 of the Federal Food,Drug, and Cosmetic Act, amended by the Project BioShield

Act of 2004) in response to requests from the CDC to makeavailable certain drugs (Tamiflu and Relenza), diagnostictests and respiratory protection devices.

Use of unapproved (unlicensed) medical treatments andtests, or use of approved treatments for unapproved uses

Pregnant mothers Class 3 Dangers (4x riskof H1N1 Flu Complications, Young adults

and children Unethical Testing Protocol
http://biotech.law.lsu.edu/blaw/H1N1-2009/R40560_20090521.pdfhttp://www.cdc.gov/h1n1flu/eua/qa.htmhttp://www.cdc.gov/h1n1flu/eua/qa.htmhttp://www.fda.gov/OHRMS/DOCKETS/98fr/E9-8922.htmhttp://www.fda.gov/OHRMS/DOCKETS/98fr/E9-8922.htmhttp://www.fda.gov/OHRMS/DOCKETS/98fr/E9-8922.htmhttp://www.fda.gov/OHRMS/DOCKETS/98fr/E9-8922.htmhttp://www.fda.gov/OHRMS/DOCKETS/98fr/E9-8922.htmhttp://www.fda.gov/OHRMS/DOCKETS/98fr/E9-8922.htmhttp://www.fda.gov/OHRMS/DOCKETS/98fr/E9-8922.htmhttp://www.fda.gov/OHRMS/DOCKETS/98fr/E9-8922.htmhttp://www.cdc.gov/h1n1flu/eua/qa.htmhttp://www.cdc.gov/h1n1flu/eua/qa.htmhttp://biotech.law.lsu.edu/blaw/H1N1-2009/R40560_20090521.pdf


36/61


Vaccines containing MF59 andASO3 have nothad Emergency Use Authorizations issued for

them--yet. USA government has purchased $698 million

dollars' worth of these adjuvants in August, 2009

US and WHO officials have announced intentions

to use these viral antigen stretching adjuvants tosupply adequate vaccine for Fall 2009 Winter2010
http://www.bloomberg.com/apps/news?pid=20601085&sid=aeKFOHbajydMhttp://www.bloomberg.com/apps/news?pid=20601085&sid=aeKFOHbajydM


37/61

THE PANDEMIC FLU MANIPULATEDPERFECT STORM

New Bioterrorism laws (passed with theexpectation of use for much more dangerous

epidemics than the current swine flu) Allow use of untested products AND

Give manufacturers an incentive to avoidcomprehensive testing (to avoid being found guilty

of willful misconduct) have Combined with the political imperative to provide

citizens with vaccines in a hurry,

Yielding a potential Perfect Storm.

SOURCE: Dr Meryl Nass MD MPH Int Med


38/61

1976 Swine Flu Vaccine Program 45 million people were vaccinated with aninadequately tested vaccine

Government gave the vaccine

manufacturers immunity from liability

Created an alternative compensationprogram

Five thousand people sought benefits forvaccine injuries

475 Guillain-Barre Syndrome

Over 30 to 50 died directly from vaccine


39/61

TESTING AND SURVEILLANCE

OF A H1N1 FLU VACCINES

Absence ofPrelicensure Clinical Trial Data

Mandatory Vaccination of All of US population will

cause death, spontaneous miscarriage,autoimmune disease and progressive neurologicaldisorders and more

Road blocks and school lockdowns of Voluntary

with Consequences vaccination with refusal metby forced quarantine with RFID steel bracelets

Legal Injunctions in all states, countries, and

Danger of violent resistance is very probable


40/61

Guillaine-Barre Paralysis Risk of A

H1N1 Flu Vaccination The British Neurological Surveillance Unit(BNSU), part of the British Association of

Neurologists, has been asked to monitor closely

any cases of GBS as the vaccine is rolled out. One senior neurologist said last night: I would not

have the swine flu jab because of the GBS risk.

There are concerns that there could be a repeat of

what became known as the 1976 debacle in theUS, where a swine flu vaccine killed 25 peoplemore than the virus itself.


41/61

Guillaine-Barre Paralysis Risk of A

H1N1 Flu Vaccination Australian National Medical Malpractice Insurancewill not insure doctors against suits forcomplications such as GBS, death, or othercomplications

CMPA Canadian Medical Protective Associationwill likewise be pressured into not protectingdoctors and nurses who participate in the NationalMandatory Vaccination Program

US Private Medical Malpractice Insurers can alsobe pressured into non-coverage for liability ofdeath, paralysis and autoimmune diseases andother complications e.g. autism, miscarriage etc.


42/61

DEADLY 'SIX' CONSEQUENCES OF FORCED

MEXICAN A H1N1 VACCINATION PROGRAMS:

1] DEPRESSION OF IMMUNE PROTECTION AGAINSTANY INFECTION AND MORE AND MORE SERIOUSHUMAN CASES OF A H1N1 WITH HIGHER CASE

FATALITIES

2] ACUTE OR CHRONIC ADJUVANT TOXIN INDUCED

NEUROLOGICAL AND AUTOIMMUNE DISEASES ORACUTE SYSTEMIC COLLAPSE AND DEATH !-- CNS

DAMAGE, BEHAVIORAL DISORDERS, MOODDISORDERS, DEMENTIA, NEUROPATHY AND CNSINDUCED DEATH !

3] STEALTH PATHOGENS IN HOT BATCHES E.G.MYCOPLASMA, VIRUSES, FUNGI AND ACUTE ORCHRONIC ILLNESS ... AUTOIMMUNE AND CANCER


43/61

DEADLY 'SIX' CONSEQUENCES OF FORCED

MEXICAN A H1N1 VACCINATION PROGRAMS: 4] RNA AND DNA PLASMA ANTIGENIC AMPLIFICATION

IN NEW TEST VACCINES CAN SWITCH ON GENESCAUSING SERIOUS IMMEDIATE HEALTH DANGERS,AUTOIMMUNE DISEASES AND CANCER INDUCTION

5] FASTER VIRAL GENETIC JUMPS TO MOREPATHOGENIC SUBSTRAINS UNDER DRUG AND

GENETICALLY ATTENTUATED FULL OR PARTIALVIRAL GENOME IN NEW TEST VACCINES...

6] NAIS TRACKING BRACELETS OR INJECTED RFIDTRACKING CHIPS AS PART OF VERIFICATION OF

IDENTITY WITH BIOMETRIC CENTRAL DATABASES TOVERIFY SAFE LICENSED TRAVEL IN THE USA ANDCOUNTRIES WORLDWIDE !-- PART OF WHO UN

WORLD PANDEMIC CONTROL MATRIXX...!!


44/61

NO H1N1 PANDEMIC 6 JUSTIFIED UNLESS

VACCINES UPGRADE PATHOGENICITY 1. The feared "2nd wave" of mutated "novel H1N1/H3N2/H5N1RECOMBINANT PANDEMIC VIRUS" has not appeared!

2. The "flu season" in the Southern Hemisphere is winding down.

3. Studies concluded by the CDC have CLEARLY SHOWN that this"lab-created" virus has average to low transmission issues

4. Yet, despite all of these facts, the WHO has not lowered the "Level6" alert down to what is a much more appropriate Level 3 or 4. Why isthiis? Simply because it is only at "Level 6" that the WHO has controlover the highly profitable MASS VACCINATION CAMPAIGN andforcing cumpulsory vaccines in the 194 treaty nations.

Given these facts, it should be obvious that the "Pandemic" will nothappen, unless and until ATTENUTATED, LIVE VIRUSES aresystematically spread throughout the world via the VACCINENEEDLES, or MED-IMMUNE NASAL SPRAYS to young children.

Sept 1st 2009 NutriMedical Report Show, Dr True Ott PhD ND


45/61

NOVARTIS SPLIT VIRUS TH1

ADJUVANT TECHNOLOGY PATENT


46/61

NOVARTIS SPLIT VIRUS TH1

ADJUVANT TECHNOLOGY PATENT Novartis applied for just such a patent on Nov. 4,2005, and the

U.S. Patent Office accepted this application and

granted US 20090047353A1 for a Split Influenza Vaccine withAdjuvants on

February 19, 2009.

Patents protecting the proprietary flu vaccine must

be applied for and secured before the pandemicvirus is released in order to minimize the

competition and maximize the profit potentials.


47/61

PANDEMRIX BIRD FLU VACCINE Europe GlaxoSmithKline's (GSK)PANDEMRIX vaccine.

This EMEA Document is very, very

revealing.

The vaccine consists of: ActiveSubstance: Pandemic influenza vaccine

(H5N1) (split virion, inactivated,adjuvanted) A/VietNam/1194/2004 NIBRG-14.

Clearly, this is BIRD FLU vaccine


48/61

Pandemrix European H5N1 Spit

Virion Pandemic Vaccine !? Injecting millions of people withPANDREMIX "adjuvanted" H5N1 Bird Fluviruses could indeed create the 'Perfect

Storm' A H1N1 recombination with plasmids in

Europes Pandemrix H5N1 Split Virionwould produce new viral index cladebranches with much higher case fatalities,and rapid human to human spread

Second wave A H1N1 lethal pandemic

wave may arise by this process


49/61

NOVARTIS 2005 PATENT FOR

H1N1 NOVEL FLU VACCINE Novartis Nov. 6, 2005 provisional patentapplication. On page 2, paragraph 32 ofthe patent publication we read, quote: The

influenza virus [that the invention vaccineis designed to protect against] may be areassortant strain, and may have beenobtained by

Reverse genetics techniques allowinfluenza viruses with desired genomesegments to be prepared in vitro using

plasmids


50/61

NOVARTIS 2005 PATENT FOR

H1N1 NOVEL FLU VACCINE African green monkey kidney cells will beused for the viral growth substrate i.e.the carrier medium. (Page 3, paragraph

0037) oil-in-water squalene-based adjuvants

will also be included (page 8 0098)recombinant and novel split vaccine,

include fragments of attenuated viruses(i.e. live pathogens) in the vaccinemedium. Source: Dr True Ott PhD ND


51/61

OPERATION BIOSHIELDREVERSE VIRAL ENGINEERING

CREATE FUTURE PATHOGENS ANDBIOWEAPONS TO INVENTCOUNTERMEASURES

DayCart latest version ofProMis Oracle 8ipredictive software to plan

Bioengineered Future Pathogens &Bioweapons

Develop Vaccines and Pharmaceuticals toblock pathogens

Invent the problem and profit from the

solution


52/61

INTERNATIONAL SWINE FLU CONFERENCEWashington, D.C., AUGUST 19TH TO 20TH 2009

Top Five Reasons to Attend the Summit Gain a broad birds eye view of the global swine

flu situation.

Get the freshest updates from hard-to-reach

country experts. Learn how your company / organization can

prepare for a pandemic.

Establish contacts with key local, federal and

international agencies involved in the fight againstswine flu.

Draw on first hand best practices from topcompanies to create solid business continuity

plans.


53/61

JURISDICTIONARY LEGAL MILITIA : INJUNCTION AGAINSTMANDATORY VOLUTARY WITH DETENTION A H1N1 VACCINES

Injunctions are orders of a court of competentjurisdiction commanding an individual,business entity, or government agency to door stop doing something.

Injunctions invoke what is called the equitablepowers of the court and, as such, thoseseeking an injunction must come to court withclean hands.

The party bringing such an action is called thepetitioner (not plaintiff). The party againstwhom the action is brought is called the

respondent (not defendant).


54/61


Injunctions are commenced by filing a petitionwith a court of competent jurisdiction (couldbe state or federal), effective service of asummons 1 and copy of the petition on the

respondent(s) by an authorized process server2

The elements that must be (1) alleged in the

petition and subsequently (2) proven by thegreater weight of admissible evidence throughthe use of discovery are: , and payment ofrequired court fees.


55/61

LEGAL VACCINEINJUNCTIONFIVE ELEMENTS

Threatened Harmto the Petitioner

Outweighs PublicInterest

Threatened Harm

to thePetitioner OutweighsHarm to Respondent

Imminent Likelihoodof Irreparable Harm

Unavailability Ofany AdequateRemedy at Law

Substantial Likelihoodof Success

Based on theAllegations

YOU WIN !!


56/61


1. Existence of an imminent likelihood of irreparableharm if the injunction is not issued,

2. Unavailability of any adequate remedy at law (i.e., an

award of money damages after the harm has occurredwill not restore the petitioner?s threatened loss,

3. The threatened harm to the petitioner outweighs anysubstantial harm to the respondent,

4. Granting the injunction will not contravene asubstantial public interest, and

5. Petitioner has a substantial likelihood of successbased on the allegations, i.e., the facts alleged are likely

to be proven and are not merely speculative.


57/61

JurisDictionary Legal Militia Start or Join aChapter in Your Town, City, State or Country

Go to www.NutriMedical.com orwww.CLAYandIRON.com and Click onProducts by Company Down toJurisDictionary and Online or theJurisDictionary Legal Militia EducationalLibrary

OR Phone 866-Law-EASY and Talk to DrFred Graves J.D. or his staffThey are one of

our great sponsorsSay to them that youwere sent to join the Legal Militia by Dr BillDeagle MD & The NutriMedical Report andCLAYandIRON SHOW
http://www.nutrimedical.com/http://www.clayandiron.com/http://www.clayandiron.com/http://www.nutrimedical.com/


58/61


Note: In the aforementionedessential elements that must be

(1) alleged and (2) proven by thegreater weight of admissibleevidence, each word has aparticular technical meaning thatwill be used by the court to readthe petition.


59/61


Note also: You need only allege those ultimate factsthat, if proven, establish all the five elements. Fail toallege sufficient facts to establish all five, and yourpetition will be dismissed for failure to state a claim on

which the court can grant relief (in some courts called acause of action). Allege too many facts, and you weakenyour case by muddying the waters beyond what is

necessary.

Note this, too: You must be able to prove all the factsyou allege, so you will surely shoot yourself in the footif you allege innuendo, assumptions, wild accusations,

etc. Stick to those facts that, if proven, will suffice toestablish all five elements.

Thats how you win!


60/61

1 2 3 4

Due Process Is the KING of ALL RIGHTS


61/61

www.NutriMedical.com

www.CLAYandIRON.com

www.LabVirus.com BLOG
http://www.nutrimedical.com/http://www.clayandiron.com/http://www.labvirus.com/http://www.labvirus.com/http://www.clayandiron.com/http://www.nutrimedical.com/